What does a low HSV‑2 IgG level of 1.11 U/mL from Quest Diagnostics with an unmeasurable inhibition assay indicate when measured four weeks after a confirmed HSV‑2 exposure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

HSV-2 IgG of 1.11 at 4 Weeks Post-Exposure: Interpretation

This result is indeterminate and highly unreliable—you cannot make any definitive diagnosis of HSV-2 infection from this test, and you must repeat serologic testing at 12 weeks post-exposure to determine if HSV-2 infection occurred. 1

Why This Result Cannot Be Trusted

Your HSV-2 IgG index value of 1.11 falls into the most problematic range for interpretation:

  • Poor specificity at low index values: Index values between 1.1–2.9 have only 39.8% specificity compared to the gold-standard Western blot, meaning more than 60% of results in this range are false positives 11

  • Timing is too early: At 4 weeks post-exposure, you are still within the antibody window period. The window period for HSV-2 IgG seroconversion can extend up to 12 weeks, so a negative or low-positive result at 4 weeks does not rule out recent infection 11

  • The unmeasurable inhibition assay is a red flag: When Quest cannot perform the inhibition assay (confirmatory test), this typically indicates the antibody level is too low or borderline to reliably confirm. This further supports that the result is indeterminate 23

What This Result Actually Means

You are in diagnostic limbo with three possible scenarios:

  1. False positive (most likely given the 60% false-positive rate at this index value)
  2. Very early true infection with antibodies just beginning to develop
  3. True negative that will remain negative at 12 weeks

The Correct Next Steps

Wait until 12 weeks (3 months) post-exposure and repeat HSV-2 IgG testing. 11

At that time:

  • If the index value is ≥3.0, this is sufficient for diagnosis without additional confirmatory testing 11
  • If the index value remains 1.1–2.9, demand confirmatory testing with either:
    • Biokit HSV-2 rapid assay (improves specificity from 93.2% to 98.7%) 11
    • Western blot (gold standard) 11

Critical Pitfalls to Avoid

Do not accept this diagnosis without confirmation. Studies show that 20% of false-positive results have index values >3.5, and your value of 1.11 is in the worst-performing range 3. Making life-altering decisions about a chronic, stigmatized infection based on a test with 60% false-positive rate is inappropriate.

Check your HSV-1 status. If you are HSV-1 positive, you are more likely to have a false-positive HSV-2 test at low index values 111. The cross-reactivity between HSV-1 antibodies and HSV-2 testing contributes to false positives.

If you had lesions at the time of exposure or develop them, get PCR/NAAT testing from the lesion—this is far more accurate than serology and provides immediate diagnostic clarity 11

Bottom Line

This test result tells you essentially nothing definitive. The combination of low index value (1.11), early timing (4 weeks), and inability to perform confirmatory inhibition testing makes this result uninterpretable. Repeat testing at 12 weeks is mandatory to determine your true HSV-2 status. 11

References

Related Questions

What does a low HSV‑2 IgG of 1.11 (with non‑measurable inhibition) obtained four weeks after a confirmed HSV‑2 exposure indicate, given the patient also has a high HSV‑1 IgG (~9)?
What does a herpes simplex virus type 2 (HSV‑2) IgG index of 9 indicate, and how should an asymptomatic patient be managed?
Is a 25–35 % probability of a borderline HSV‑2 IgG result considered a high chance of true early HSV‑2 infection?
What does a high HSV‑2 IgG antibody index indicate and how should it be managed?
My HSV serology shows positive IgG for HSV‑1 (10.9) and HSV‑2 (1.53) and an indeterminate IgM for HSV‑2 pending; what does this indicate and how should I manage it?
What transdermal estrogen regimen and progestin protection should be used for a 47‑year‑old woman with low estradiol, anxiety, insomnia, and worsening migraines who wishes to avoid partner exposure to topical creams?
In a 12-year-old child with nutritional deficiency presenting with blurred vision, what is the appropriate treatment?
For a patient who reports that oral micronized progesterone and a transdermal estradiol patch keep her wide awake, what alternative progesterone regimen should be recommended to manage low estradiol, anxiety, insomnia, and migraine?
What antidepressant is recommended for a male patient with significant alcohol use disorder, liver cirrhosis, recent traumatic brain injury with bilateral subdural hygroma, femoral neck fracture, and chronic splenic venous thrombosis?
How many days of equivalent background radiation does a standard screening mammogram deliver?
Is glyceryl trinitrate (nitroglycerin) contraindicated for chest pain in a patient with severe aortic stenosis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.